Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01556087 · ClinicalTrials.gov registry record · Phase 3
Distress Tolerance and Buprenorphine
A Phase 3 study, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 59
- Enrollment target
NCT01556087 is a Phase 3 study that has completed, run by Butler Hospital. The registered enrollment target is 59 participants.
The verdict
NCT01556087, a Phase 3 study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 59 participants
- Enrollment target
Study Summary
The investigators propose that inability to tolerate the distress of opioid withdrawal and the negative affect associated with early abstinence are key factors in early illicit opioid lapse and subsequent buprenorphine treatment drop-out. Our intervention aimed at increasing distress tolerance is designed to increase treatment adherence.
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Distress Tolerance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01556087
The ClinicalTrials.gov registry entry for NCT01556087 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Education is the first listed.
NCT01556087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01556087 about?
NCT01556087 is a clinical study titled "Distress Tolerance and Buprenorphine". The investigators propose that inability to tolerate the distress of opioid withdrawal and the negative affect associated with early abstinence are key factors in early illicit opioid lapse and subsequent buprenorphine treatment drop-out. Our intervention aimed at increasing distress tolerance is de...
What is the current status of trial NCT01556087?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 59 participants. The study started on 2012-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01556087?
The interventions under investigation include: Health Education (BEHAVIORAL), Distress Tolerance (BEHAVIORAL).
Who is sponsoring clinical trial NCT01556087?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.